Valsartan, a new angiotensin II antagonist for the treatment of essential hypertension: efficacy and safety compared to hydrochlorothiazide

Management guidelines in essential hypertension: report of the second working party of the British Hypertension Society.

Peter Sever, Gareth Beevers, C. J. Bulpitt et al. · BMJ · 1993 · 357 citations · Full text

Medicine, Cardiology, Pharmacotherapy +17

Valsartan, a new angiotensin II antagonist for the treatment of essential hypertension: A comparative study of the efficacy and safety against amlodipine*

L Corea, Ondina Cardoni, Roberto Fogari et al. · Clinical Pharmacology & Therapeutics · 1996 · 135 citations

Pharmacy, Pharmacology, Pharmacotherapy +17

Valsartan: Preclinical and Clinical Profile of an Antihypertensive Angiotensin‐II Antagonist

Leoluca Criscione, William A. Bradley, Peter Bühlmayer et al. · Cardiovascular Drug Reviews · 1995 · 132 citations

Medicine, Cardiology, Pharmacology +14

Comparison of the angiotensin II antagonist losartan with the angiotensin converting enzyme inhibitor enalapril in patients with essential hypertension

I. Tikkanen, Per Omvik · Journal of Hypertension · 1995 · 115 citations

Pharmacy, Pharmacology, Pharmacotherapy +17

Clinical Experience With the Angiotensin II Receptor Antagonist Losartan

Michael A. Weber · American Journal of Hypertension · 1992 · 83 citations

Medicine, Pharmacology, Pharmacotherapy +14